Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:1562-1566
doi: 10.1161/01.CIR.0000061521.15730.6E
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kavey, R.-E. W.
Right arrow Articles by Taubert, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kavey, R.-E. W.
Right arrow Articles by Taubert, K.
Related Collections
Right arrow Primary prevention
Right arrow Pathophysiology
Right arrow Risk Factors

(Circulation. 2003;107:1562.)
© 2003 American Heart Association, Inc.


AHA Scientific Statement

American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood

Rae-Ellen W. Kavey, MD; Stephen R. Daniels, MD, PhD; Ronald M. Lauer, MD; Dianne L. Atkins, MD; Laura L. Hayman, PhD, RN; Kathryn Taubert, PhD


Key Words: AHA Scientific Statements • pediatrics • atherosclerosis • cardiovascular diseases • prevention


*    Introduction
up arrowTop
*Introduction
down arrowSelected Readings by Subject
 
Atherosclerotic cardiovascular disease remains the leading cause of both death and disability in North America. Evidence that most cardiovascular disease is preventable led to development of the American Heart Association’s initial "Guide to the Primary Prevention of Cardiovascular Disease" in 1996 and the updated version in 2002. Those guidelines do not address prevention in children, a group for whom primary prevention should hold the most promise. Emergence of multiple lines of evidence with regard to the importance of known risk factors for atherosclerotic disease in children and young adults has provided the impetus to develop guidelines for primary prevention in this young population.

Pathological studies have shown that both the presence and extent of atherosclerotic lesions at autopsy after unexpected death of children and young adults correlate positively and significantly with established risk factors, namely low-density lipoprotein cholesterol, triglycerides, systolic and diastolic blood pressure, body mass index, and presence of cigarette smoking. Findings from the Bogalusa study indicate that as the number of cardiovascular risk factors increases, so does the pathological evidence for atherosclerosis in the aorta and coronary arteries beginning in early childhood. Electron beam computed tomography of coronary artery calcium and increased carotid artery intima-media thickness, an ultrasound measure of carotid artery atherosclerosis, have been evaluated in 29- to 39-year-olds monitored from 4 years of age. Significant risk predictors for coronary artery calcium were obesity and elevated blood pressure in childhood and increased body mass index and dyslipidemia as young adults. Multiple epidemiological studies have demonstrated a disturbing increase in the prevalence of obesity beginning in childhood, with at least 22% of 6- to 17-year-olds diagnosed as overweight. This is a cause for particular concern because of the strong association between obesity and hypertension, dyslipidemia, and type II diabetes mellitus beginning in childhood. Long-term follow-up studies have demonstrated tracking of obesity, hypercholesterolemia, and hypertension from childhood into adult life. There is now substantial scientific evidence documenting the acquisition of behaviors associated with risk factors in childhood; these include dietary habits, physical activity behaviors, and the use of tobacco. Finally, an increasing body of research now documents the safety and success of intervention to reduce risk factors in childhood. These studies include the Dietary Intervention Study in Children trial, which demonstrated the safety and efficacy of a low-fat diet in children with hypercholesterolemia; skill-training programs in smoking prevention in adolescents; the Child and Adolescent Trial for Cardiovascular Health Study, which increased physical activity levels in children by using elementary school-based programs; and other successful long-term family-based treatment programs for childhood obesity.

There has not been nor will likely ever be a controlled trial comparing the effect of risk reductions beginning in childhood on the subsequent development of atherosclerotic disease. The existing evidence indicates that primary prevention of atherosclerotic disease should begin in childhood. The following guidelines represent a practical approach to cardiovascular health promotion and identification and management of known risk factors for cardiovascular disease in children and young adults. These guidelines complement other American Heart Association guidelines and should be useful for primary care providers, specialists, and parents of children and adolescents. The writing group that developed this statement considered the National Cholesterol Education Program Pediatric Panel Report, the second Task Force report on the diagnosis and management of hypertension in childhood, the update of that task force report by the National High Blood Pressure Education Program, and multiple additional publications, which are included in the reading list. Two major primary prevention strategies for children and adolescents are outlined in the tables below: (1) Population guidelines are directed cardiovascular health promotion for the entire pediatric population, whereas (2) individual guidelines focus on the identification and management of children and adolescents at highest risk for atherosclerotic disease.

The population guidelines, which apply to all children and adolescents, are presented in Table 1. In this table, the goals are presented in the left column and the recommendations for achieving those goals are presented in the right. Table 2 presents general and risk factor-specific guidelines for identifying pediatric patients at high risk of future cardiovascular disease. Finally, Table 3 presents goals and recommendations to achieve the goals of reducing risks in children and adolescents identified at high risk of future cardiovascular disease.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Guidelines for Cardiovascular Health Promotion in All Children and Adolescents


View this table:
[in this window]
[in a new window]
 
TABLE 2. Guidelines for Identification of Children and Adolescents at High Risk of CVD


View this table:
[in this window]
[in a new window]
 
TABLE 3. Guidelines for Cardiovascular Risk Reduction: Intervention for Children and Adolescents With Identified Risk

These guidelines present a conservative approach in an easy-to-use format identifying risk factors in childhood and safely modifying those identified without harm to the growing child. The American Heart Association’s Council on Cardiovascular Disease in the Young has developed a cardiovascular health schedule that allows risk factor identification and modification within the framework of routine pediatric care, and this approach is highly recommended (Williams et al, reference 7 in section VI). These guidelines are complementary to the recommendations published by Williams et al. Risk reduction has been shown to delay the onset and modify the course of atherosclerotic disease in adults; with evidence for the extent and importance of identified risk factors in the young, the time for primary prevention beginning in childhood has come.


*    Selected Readings by Subject
up arrowTop
up arrowIntroduction
*Selected Readings by Subject
 
I. Pathological Evidence for Risk Factor Impact in the Young

  1. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA. 1990;264:3018–3024.
  2. McGill HC Jr, McMahan CA, Zieske AW, et al. Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation. 2001;103:1546–1550.
  3. Newman WP 3rd, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med. 1986;314:138–144.
  4. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med. 1998;338:1650–1656.
  5. Mahoney LT, Burns TL, Stanford W, et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol. 1996;27:277–284.

II. Prevalence of Obesity/Type 2 Diabetes Mellitus

  1. Luepker RV, Jacobs DR, Prineas RJ, et al. Secular trends of blood pressure and body size in a multi-ethnic adolescent population: 1986 to 1996. J Pediatr. 1999;134:668–674.
  2. Morrison JA, James FW, Sprecher DL, et al. Sex and race differences in cardiovascular disease risk factor changes in schoolchildren, 1975–1990: the Princeton School Study. Am J Public Health. 1999;89:1708–1714.
  3. Troiano RP, Flegal KM, Kuczmarski RJ, et al. Overweight prevalence and trends for children and adolescents: the National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med. 1995;149:1085–1091.
  4. Pinhas-Hamiel O, Dolan LM, Daniels SR, et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996;128(5 Pt 1):608–615.
  5. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr. 2000;136:664–672.

III. Tracking of Risk Factors From Childhood Into Adult Life

  1. Lauer RM, Lee J, Clarke WR. Factors affecting the relationship between childhood and adult cholesterol level: the Muscatine Study. Pediatrics. 1988;82:309–318.
  2. Lauer RM, Clarke WR. Childhood risk factors for high adult blood pressure: the Muscatine Study. Pediatrics. 1989;84;633–641.
  3. Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997;337:869–873.

IV. Acquisition of Risk Behaviors in Childhood

  1. Oliveria SA, Ellison RC, Moore LL, et al. Parent-child relationships in nutrient intake: the Framingham Children’s Study. Am J Clin Nutr. 1992;56:593–598.
  2. Feunekes GI, de Graaf C, Meyboom S, et al. Food choice and fat intake of adolescents and adults: associations of intakes within social networks. Prev Med. 1998;27(5 Pt 1):645–656.
  3. Janz KF, Dawson JD, Mahoney LT. Tracking physical fitness and physical activity from childhood to adolescence: the Muscatine study. Med Sci Sports Exerc. 2000;32:1250–1257.
  4. Powell KE, Dysinger W. Childhood participation in organized school sports and physical education as precursors of adult physical activity. Am J Prev Med. 1987;3:276–281.
  5. Rojas NL, Killen JD, Haydel KF, et al. Nicotine dependence among adolescent smokers. Arch Pediatr Adolesc Med. 1998;152:151–156.

V. Intervention Trials

  1. Obarzanek E, Kimm SY, Barton BA, et al. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics. 2001;107:256–264.
  2. Flynn BS, Warden JK, Secker-Walker R. Cigarette smoking prevention: effects of mass media and school interventions targeted to gender and age groups. J Health Educ. 1995;26:545–551.
  3. Luepker RV, Perry CL, McKinlay SM, et al. Outcomes of a field trial to improve children’s dietary patterns and physical activity: the Child and Adolescent Trial for Cardiovascular Health. CATCH collaborative group. JAMA. 1996;275:768–776.
  4. Sallis JF, McKenzie TL, Alcaraz JE, et al. The effects of a 2-year physical education program (SPARK) on physical activity and fitness in elementary school students. Sports, Play and Active Recreation for Kids. Am J Public Health. 1997;87:1328–1334.

VI. Pediatric Consensus Statements

  1. American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3 Pt 2):525–584.
  2. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics. 1996;98(4 Pt 1):649–658.
  3. Barlow SE, Dietz WH. Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics. 1998;102:E29.
  4. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23:381–389.
  5. American Academy of Pediatrics, Committee on Public Education. Media education. Pediatrics. 1999;104(2 Pt 1):341–343.
  6. Cavill N, Biddle S, Sallis JF. Health enhancing physical activity for young people: statement of the United Kingdom expert consensus conference. Pediatr Exerc Sci. 2001;13:12–25.
  7. Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2002;106:143–160. [Erratum Circulation. 2002;106:1178.]


*    Footnotes
 
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.

This statement has been co-published in the April 2003 issue of The Journal of Pediatrics.

This statement was approved by the American Heart Association Science Advisory and Coordinating Committee on November 4, 2002. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0248. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.




This article has been cited by other articles:


Home page
PediatricsHome page
S. R. Daniels, F. R. Greer, and and the Committee on Nutrition
Lipid Screening and Cardiovascular Health in Childhood
Pediatrics, July 1, 2008; 122(1): 198 - 208.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. C. McGill Jr, C. A. McMahan, and S. S. Gidding
Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study
Circulation, March 4, 2008; 117(9): 1216 - 1227.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. J. Albers, S. M. Marcovina, G. Imperatore, B. M. Snively, J. Stafford, W. Y. Fujimoto, E. J. Mayer-Davis, D. B. Petitti, C. Pihoker, L. Dolan, et al.
Prevalence and Determinants of Elevated Apolipoprotein B and Dense Low-Density Lipoprotein in Youths with Type 1 and Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 735 - 742.
[Abstract] [Full Text] [PDF]


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
R. A. Meriwether, F. Lobelo, and R. R. Pate
Themed Review: Clinical Interventions to Promote Physical Activity in Youth
American Journal of Lifestyle Medicine, February 1, 2008; 2(1): 7 - 25.
[Abstract] [PDF]


Home page
CirculationHome page
C. G. Magnussen, O. T. Raitakari, R. Thomson, M. Juonala, D. A. Patel, J. S.A. Viikari, J. Marniemi, S. R. Srinivasan, G. S. Berenson, T. Dwyer, et al.
Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study
Circulation, January 1, 2008; 117(1): 32 - 42.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. L. Hayman, J. C. Meininger, S. R. Daniels, B. W. McCrindle, L. Helden, J. Ross, B. A. Dennison, J. Steinberger, and C. L. Williams
Primary Prevention of Cardiovascular Disease in Nursing Practice: Focus on Children and Youth: A Scientific Statement From the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism
Circulation, July 17, 2007; 116(3): 344 - 357.
[Full Text] [PDF]


Home page
PediatricsHome page
US Preventive Services Task Force
Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement
Pediatrics, July 1, 2007; 120(1): e215 - e219.
[Full Text] [PDF]


Home page
CMAJHome page
D. C.W. Lau, J. D. Douketis, K. M. Morrison, I. M. Hramiak, A. M. Sharma, E. Ur, and for members of the Obesity Canada Clinical Practic
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]
Can. Med. Assoc. J., April 10, 2007; 176(8): S1 - S13.
[Full Text] [PDF]


Home page
CMAJHome page
D. C.W. Lau, J. D. Douketis, K. M. Morrison, I. M. Hramiak, A. M. Sharma, E. Ur, and pour les membres du Groupe d'experts d'Obesite Can
Lignes directrices canadiennes de 2006 sur la prise en charge et la prevention de l'obesite chez les adultes et les enfants [sommaire]
Can. Med. Assoc. J., April 10, 2007; 176(8): SF1 - SF14.
[Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
D. B. Petitti, G. Imperatore, S. L. Palla, S. R. Daniels, L. M. Dolan, A. K. Kershnar, S. Marcovina, D. J. Pettitt, C. Pihoker, and for the SEARCH for Diabetes in Youth Study Group
Serum Lipids and Glucose Control: The SEARCH for Diabetes in Youth Study
Arch Pediatr Adolesc Med, February 1, 2007; 161(2): 159 - 165.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
K. J. Dilley, L. A. Martin, C. Sullivan, R. Seshadri, H. J. Binns, and for the Pediatric Practice Research Group
Identification of Overweight Status Is Associated With Higher Rates of Screening for Comorbidities of Overweight in Pediatric Primary Care Practice
Pediatrics, January 1, 2007; 119(1): e148 - e155.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Circulation, December 12, 2006; 114(24): 2710 - 2738.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
E. C. Reis, K. E. Kip, O. C. Marroquin, M. Kiesau, L. Hipps Jr, R. E. Peters, and S. E. Reis
Screening Children to Identify Families at Increased Risk for Cardiovascular Disease
Pediatrics, December 1, 2006; 118(6): e1789 - e1797.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. J. Orchard, T. Costacou, A. Kretowski, and R. W. Nesto
Type 1 diabetes and coronary artery disease.
Diabetes Care, November 1, 2006; 29(11): 2528 - 2538.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Juonala, J. S.A. Viikari, T. Ronnemaa, L. Taittonen, J. Marniemi, and O. T. Raitakari
Childhood C-Reactive Protein in Predicting CRP and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1883 - 1888.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. R. Srinivasan, M. G. Frontini, J. Xu, and G. S. Berenson
Utility of Childhood Non-High-Density Lipoprotein Cholesterol Levels in Predicting Adult Dyslipidemia and Other Cardiovascular Risks: The Bogalusa Heart Study
Pediatrics, July 1, 2006; 118(1): 201 - 206.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. C. Eppens, M. E. Craig, J. Cusumano, S. Hing, A. K.F. Chan, N. J. Howard, M. Silink, and K. C. Donaghue
Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 Diabetes.
Diabetes Care, June 1, 2006; 29(6): 1300 - 1306.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Salerno, V. Esposito, V. Farina, G. Radetti, A. Umbaldo, D. Capalbo, L. Spinelli, S. Muzzica, G. Lombardi, and A. Colao
Improvement of Cardiac Performance and Cardiovascular Risk Factors in Children with GH Deficiency after Two Years of GH Replacement Therapy: An Observational, Open, Prospective, Case-Control Study
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1288 - 1295.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
American Heart Association, S. S. Gidding, B. A. Dennison, L. L. Birch, S. R. Daniels, M. W. Gilman, A. H. Lichtenstein, K. T. Rattay, J. Steinberger, N. Stettler, et al.
Dietary Recommendations for Children and Adolescents: A Guide for Practitioners
Pediatrics, February 1, 2006; 117(2): 544 - 559.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al.
Managing Abnormal Blood Lipids: A Collaborative Approach
Circulation, November 15, 2005; 112(20): 3184 - 3209.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
J. T. Mallare, A. H. Karabell, P. Velasquez-Mieyer, S. R.S. Stender, and M. L. Christensen
Current and Future Treatment of Metabolic Syndrome and Type 2 Diabetes in Children and Adolescents
Diabetes Spectr, October 1, 2005; 18(4): 220 - 228.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Endorsed by the American Academy of Pediatrics, S. S. Gidding, B. A. Dennison, L. L. Birch, S. R. Daniels, M. W. Gilman, A. H. Lichtenstein, K. T. Rattay, J. Steinberger, N. Stettler, et al.
Dietary Recommendations for Children and Adolescents: A Guide for Practitioners: Consensus Statement From the American Heart Association
Circulation, September 27, 2005; 112(13): 2061 - 2075.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. H. Eckel, S. R. Daniels, A. K. Jacobs, and R. M. Robertson
America's Children: A Critical Time for Prevention
Circulation, April 19, 2005; 111(15): 1866 - 1868.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Godoy-Matos, L. Carraro, A. Vieira, J. Oliveira, E. P. Guedes, L. Mattos, C. Rangel, R. O. Moreira, W. Coutinho, and J. C. Appolinario
Treatment of Obese Adolescents with Sibutramine: A Randomized, Double-Blind, Controlled Study
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1460 - 1465.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Mitani, H. Sawada, H. Hayakawa, K. Aoki, H. Ohashi, M. Matsumura, K. Kuroe, H. Shimpo, M. Nakano, and Y. Komada
Elevated Levels of High-Sensitivity C-Reactive Protein and Serum Amyloid-A Late After Kawasaki Disease: Association Between Inflammation and Late Coronary Sequelae in Kawasaki Disease
Circulation, January 4, 2005; 111(1): 38 - 43.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. Silverstein, G. Klingensmith, K. Copeland, L. Plotnick, F. Kaufman, L. Laffel, L. Deeb, M. Grey, B. Anderson, L. A. Holzmeister, et al.
Care of Children and Adolescents With Type 1 Diabetes: A statement of the American Diabetes Association
Diabetes Care, January 1, 2005; 28(1): 186 - 212.
[Full Text] [PDF]


Home page
PediatricsHome page
J. O'Loughlin, G. Paradis, and M. Lambert
If It's Not Worth Doing, It's Not Worth Doing Well: In Reply
Pediatrics, January 1, 2005; 115(1): 196 - 197.
[Full Text] [PDF]


Home page
CirculationHome page
L. L. Hayman, C. L. Williams, S. R. Daniels, J. Steinberger, S. Paridon, B. A. Dennison, and B. W. McCrindle
Cardiovascular Health Promotion in the Schools: A Statement for Health and Education Professionals and Child Health Advocates From the Committee on Atherosclerosis, Hypertension, and Obesity in Youth (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association
Circulation, October 12, 2004; 110(15): 2266 - 2275.
[Full Text] [PDF]


Home page
PediatricsHome page
National High Blood Pressure Education Program Wor
The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents
Pediatrics, August 1, 2004; 114(2/S2): 555 - 576.
[Full Text] [PDF]


Home page
Pediatr. Rev.Home page
B. Belay, P. Belamarich, and A. D. Racine
Pediatric Precursors of Adult Atherosclerosis
Pediatr. Rev., January 1, 2004; 25(1): 4 - 16.
[Full Text] [PDF]


Home page
Diabetes CareHome page
Standards of Medical Care in Diabetes
Diabetes Care, January 1, 2004; 27(90001): s15 - 35.
[Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Approaches to Cardiovascular Disease and Its Treatment
Diabetes Care, December 1, 2003; 26(12): 3342 - 3348.
[Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
S. Cook, M. Weitzman, P. Auinger, M. Nguyen, and W. H. Dietz
Prevalence of a Metabolic Syndrome Phenotype in Adolescents: Findings From the Third National Health and Nutrition Examination Survey, 1988-1994
Arch Pediatr Adolesc Med, August 1, 2003; 157(8): 821 - 827.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association
Management of Dyslipidemia in Children and Adolescents With Diabetes
Diabetes Care, July 1, 2003; 26(7): 2194 - 2197.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kavey, R.-E. W.
Right arrow Articles by Taubert, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kavey, R.-E. W.
Right arrow Articles by Taubert, K.
Related Collections
Right arrow Primary prevention
Right arrow Pathophysiology
Right arrow Risk Factors